FCM
BBOT

Farallon Capital Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Farallon Capital Management’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$6.39M Hold
600,000
– – 0.03% 78
2025
Q1 		$6.78M Hold
600,000
– – 0.03% 72
2024
Q4 		$6.3M Hold
600,000
– – 0.03% 77
2024
Q3 		$6.27M Hold
600,000
– – 0.03% 86
2024
Q2 		$6.13M Hold
600,000
– – 0.03% 83
2024
Q1 		$6.21M Buy
+600,000
New +$6.21M 0.03% 95